Request Discount

In-vitro Transcription Templates Market (Disease - Lifestyle Diseases, Cancer, Genetic Disease, and Others; Treatment Type - Vaccine, and Therapeutic; End Users - Biotechnology Companies, Research and Academic Institutions, Pharmaceutical Companies, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027

  • Published : February, 2022

  • Rep Id : HC08749

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the in-vitro transcription templates market provides an in-depth analysis of segments and sub-segments in the global as well as regional in-vitro transcription templates market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional in-vitro transcription templates market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of the global in-vitro transcription templates market. According to the report, the global in-vitro transcription templates market is projected to grow at a CAGR of approximately 20% over the forecast period of 2021-2027.


Market Insight

The revenue generated by the market was approximately USD 218.4 billion in 2021 and is expected to reach approximately USD 654.3 billion in 2027. A pure linear DNA template with a promoter, ribonucleotide triphosphates, a buffer solution comprising DTT and magnesium ions, and a suitable phage RNA polymerase are all required for in vitro transcription. The transcription reaction's exact settings are determined by the amount of RNA required for a specific application. Thus, synthesised RNA transcripts are obtained from in-vitro transcription. Synthesized RNA transcripts are further used for analysing cellular RNA functionality in methods such as splicing, RNA processing, intracellular transport, viral infectivity, and translation. In-vitro transcription templates are used in a variety of applications such as drug discovery, diagnosis, and treatment of various diseases such as chronic and genetic diseases


The prevalence of chronic diseases such as cancer and genetic disorders and diseases is propelling the growth of the market. The demand for early diagnosis of these diseases and effective medical treatments and therapeutics for the same is growing rapidly. Pharmaceutical companies are focusing on developing RNA-based diagnostics for cancer and genetic disorders. Also, the application of in-vitro transcription templates in targeted drug delivery and drug discovery is growing. The level of biotechnology and further growing investments in it are also propelling the growth of the market. Private and public funding for the development of biotechnology is also growing, which will be beneficial for the market. The market's growth may be stifled due to the high cost and expertise required for the in-vitro transcription templates procedure. The growing investment in the R & D of in-vitro transcription templates is expected to provide new growth opportunities.


Chronic diseases such as cancer and other genetic disorders have been prevalent in North America. The existing diagnostics and treatments for these diseases are falling short of tackling these diseases. Therefore, the demand for more efficient early diagnostics and therapeutics for chronic diseases and genetic disorders is growing over time. Thus, it has paved the way for the applications of in-vitro transcription templates in drug discovery, precision medicine, and diagnosis methods. North America has an advanced medical technology base with researchers having years of experience, which has in turn greatly leveraged the R&D of in-vitro transcription templates in North America. Additionally, huge investments from governments and private players in the development of in-vitro transcription templates have catapulted the market. Also, North America is a domestic market for market players such as Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Synbio Technologies, and Promega Corporation. With such a high concentration of companies, the growth of the market in North America has been exponential.

 In-vitro Transcription Templates Market


Segment Covered

The report on global in-vitro transcription templates market covers segments such as disease, treatment type, and end users. On the basis of disease, the sub-markets include lifestyle diseases, cancer, genetic disease, and others. On the basis of treatment type, the sub-markets include vaccine, and therapeutic. On the basis of end users, the sub-markets include biotechnology companies, research and academic institutions, pharmaceutical companies, and others.


Companies Profiled:

The report provides profiles of the companies in the market such as Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Enzynomics co Ltd., Promega Corporation, Enzo Life Sciences, Inc., Takara Bio Company, Qiagen NV, Danaher Corporation, Lucigen Corporation, and Synbio Technologies.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of in-vitro transcription templates market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount